News for Healthier Living

Antibody Shows Promise Against Obesity-related Liver Disease and Atherosclerosis in Mice

Latest research in the FASEB Journal reveals an antibody called bFKB1 improves liver disease and atherosclerosis in a mouse model of metabolic dysfunction-associated steatohepatitis (MASH), which is associated with obesity.

October 28, 2024


October 31 2024

October 30 2024

October 29 2024

October 28 2024

October 27 2024

October 26 2024

October 25 2024

October 24 2024

October 23 2024

October 22 2024

October 21 2024

October 20 2024

October 19 2024

October 18 2024

October 17 2024